Cognitive Bias Modification for Obsessive-Compulsive Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new digital training called Cognitive Bias Modification for Interpretation (CBM-I) to assist individuals with obsessive-compulsive disorder (OCD). The goal is to determine if this tool can alter thought patterns by practicing tasks that may alleviate OCD symptoms. Participants will be divided into two groups: one will use the CBM-I tool, while the other will receive standard psychoeducational therapy sessions for comparison. The study seeks adults with OCD who are part of a treatment program for the disorder. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could enhance OCD treatment options.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your usual treatment, as the study is an addition to standard OCD treatment.
What prior data suggests that this digital intervention is safe for OCD patients?
Research has shown that Cognitive Bias Modification for Interpretation (CBM-I) is generally safe. Although specific safety data for CBM-I is lacking, it involves a digital training task that alters how individuals interpret information. This non-invasive training does not involve physical procedures and is intended to complement regular treatment for obsessive-compulsive disorder (OCD). Participants in similar techniques have not reported major side effects, suggesting that CBM-I is well-tolerated.12345
Why are researchers excited about this trial?
Researchers are excited about Cognitive Bias Modification for Obsessive-Compulsive Disorder (OCD) because it offers a fresh approach by targeting interpretation bias, a cognitive distortion often linked to OCD symptoms. Unlike traditional treatments like cognitive-behavioral therapy (CBT) and medications that focus on managing symptoms or altering behavior, this method directly addresses the underlying cognitive biases contributing to the disorder. By providing digital cognitive training, it allows for a personalized and potentially more accessible intervention, which could enhance the effectiveness of standard treatment options. This innovative approach holds promise for improving outcomes for individuals with OCD.
What evidence suggests that this trial's treatments could be effective for OCD?
Research has shown that Cognitive Bias Modification for Interpretation (CBM-I), a treatment in this trial, might help reduce obsessive-compulsive beliefs by altering how individuals interpret information. Studies have found that online CBM-I training can benefit people with OCD, particularly by reducing negative thoughts. Previous trials suggest that CBM-I effectively targets obsessive-compulsive beliefs, helping to change them positively. These findings indicate that CBM-I could improve symptoms in people with OCD by directly addressing and altering harmful thought patterns.13467
Are You a Good Fit for This Trial?
This trial is for adults over 18 with a primary diagnosis of OCD, confirmed by specific clinical assessments. Participants must be able to complete computer tasks and consent to the main study protocol. Those with acute psychosis or a psychotic disorder cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive up to 12 sessions of Cognitive Bias Modification for Interpretation (CBM-I) or psychoeducation as a control condition
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive bias modification for interpretation bias
- Psychoeducation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mclean Hospital
Lead Sponsor